Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5836 AL 5850

Validation of the German Version of the Movement Disorder Society Non-Motor Scale (MDS-NMS)

Bendig J, Frank A, Lipska-Dieck A, Wunderlich K, Geißler-Lösch D, Wurster I, Kemmner R, Brockmann K, Luo S, Goetz CG, Stebbins GT, Martinez-Martin P, Mestre TA, Sanchez-Ferro A, Kurtis MM, Tosin MHS, Balestrino R, Lin CR, Gasca-Salas C, Reichmann H, Falkenburger BH.

Mov Disord Clin Pract. 2026 May;13(5):1346-1348. doi: 10.1002/mdc3.70486. Epub 2025 Dec 22.

Effectiveness of Fully Immersive Virtual Reality Rehabilitation for Balance, Motor Function, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-Analysis

Ishaq S, Shah IA, Lee SD, Wu BT.

Am J Phys Med Rehabil. 2026 Apr 1;105(4):303-311. doi: 10.1097/PHM.0000000000002872. Epub 2025 Nov 19.

Self-delivered arousal-heightening stimuli to improve mobility in persons with parkinsonism: A case series

Vissers G, Tosserams A, Bloem BR, Nonnekes J.

J Parkinsons Dis. 2026 Feb;16(1):185-189. doi: 10.1177/1877718X251409029. Epub 2025 Dec 22.

Adult neurogenesis dysfunction in Parkinson's disease: Molecular pathology and functional implications

He X, Huang T, Yang A, Li Y, Bai L, Chen Y, Bai J, Zhang X.

Pathol Res Pract. 2026 Feb;278:156340. doi: 10.1016/j.prp.2025.156340. Epub 2025 Dec 20.

Speed-dependent changes in shoulder-hip coordination and upper limb variability during gait in older adults with Parkinson's disease

Cabeleira MEP, Ivaniski-Mello A, Martins VF, Peyré-Tartaruga LA, Martinez FG, Cechetti F.

Hum Mov Sci. 2026 Feb;105:103449. doi: 10.1016/j.humov.2025.103449. Epub 2025 Dec 22.

Biallelic CAG repeat expansion in the ATXN2 gene presenting with parkinsonism and spasticity

Osakada Y, Matsuoka C, Nakano Y, Taira Y, Yunoki T, Fukui Y, Morihara R, Takemoto M, Kawahara Y, Kutoku Y, Takaki M, Yokota O, Yamashita T, Ishiura H.

Parkinsonism Relat Disord. 2026 Feb;143:108168. doi: 10.1016/j.parkreldis.2025.108168. Epub 2025 Dec 17.

Initiating foslevodopa infusion in Parkinson disease: a pragmatic study

Cocco A, Zangaglia R, Belluscio G, Avenali M, Valentino F, Calabrese R, De Santis T, Polverino P, Albanese A.

Parkinsonism Relat Disord. 2026 Feb;143:108142. doi: 10.1016/j.parkreldis.2025.108142. Epub 2025 Dec 17.

Comparative In silico evaluation of c-Abl inhibitors for Parkinson's disease therapy

Kumar DB, Subramanya SK, Thakur P.

Biochem Biophys Res Commun. 2026 Jan 25;797:153175. doi: 10.1016/j.bbrc.2025.153175. Epub 2025 Dec 23.

Wirelessly transmitted subthalamic nucleus signals decode endogenous pain levels in Parkinson's disease patients

Reza A, Yanagisawa T, Tani N, Fukuma R, Emura T, Oshino S, Seymour B, Kishima H.

Neurobiol Dis. 2026 Feb;219:107235. doi: 10.1016/j.nbd.2025.107235. Epub 2025 Dec 22.

Telepsychotherapy Improves Health-Related Quality of Life in Parkinson's Disease

Liong C, Interian A, Dobkin RD.

Am J Geriatr Psychiatry. 2026 Apr;34(4):422-433. doi: 10.1016/j.jagp.2025.11.010. Epub 2025 Nov 22.

Causal models and network instability in neurological and psychiatric disorders: Computational and clinical perspectives

Nyatega CO, Li Q, Nie W, Adamu MJ, Li S.

Behav Brain Res. 2026 Mar 12;501:116007. doi: 10.1016/j.bbr.2025.116007. Epub 2025 Dec 23.

Cytokine-Microglia Interactions in Neuroinflammation: Mechanisms, Disease Dynamics, and Therapeutic Strategies

Zhang F, Yang W, Sun R, Duan X, Yang Y, Wang A, Tian Y.

Antioxid Redox Signal. 2026 Feb;44(7-9):311-331. doi: 10.1177/15230864251401591. Epub 2025 Dec 26.

Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids

Flores-León M, Outeiro TF.

Mov Disord. 2026 Mar;41(3):581-595. doi: 10.1002/mds.70167. Epub 2025 Dec 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias